JP MORGAN/PUT/PFIZER INC/28/0.1/16.08.24 | Delayed Börse Stuttgart 10:50:59 12/07/2024 BST | ||
| 0.064 EUR | -18.99% |
|
| Current month | -34.17% | ||
| 1 month | -28.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 12/07/24 | 0.064 | -18.99% |
| 11/07/24 | 0.079 | -28.18% |
| 10/07/24 | 0.11 | +10.00% |
| 09/07/24 | 0.1 | +6.38% |
| 08/07/24 | 0.094 | -14.55% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 10:50 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | J.P. Morgan |
| WKN | JK1KML |
| ISIN | DE000JK1KML5 |
| Date issued | 24/01/2024 |
| Strike | 28 $ |
| Maturity | 16/08/2024 (36 Days) |
| Parity | 10 : 1 |
| Emission price | 0.22 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.33 € |
|---|---|
| Lowest since issue | 0.063 € |
| Spread | 0.01 € |
| Spread % | 13.16% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66
USD
Average target price
32.01
USD
Spread / Average Target
+11.68%
- Stock Market
- Warrants
- Warrant